Tuxiong Huang - Publications, H-index & Citations

Tuxiong Huang

guangdong provincial key laboratory of urological diseases

14H指数

39论文数

1.0K被引数

收录论文 13

发表时间

Preclinical Assessment of HLA-A*02:01-Restricted PSMA and STEAP1 Epitopes for Peptide-Based Immunotherapy in Prostate Cancer 前列腺癌肽基免疫治疗的HLA-A*02:01限制性PSMA和STEAP1表位的临床前评估

drug design; development and therapy

IF0

2026-02-18

OAAI

Yueting Huang; Yang Yang; Yanni Xie; Yue Shu; Siqi Yang; Xuezhi Long; Zhipeng Wen; Xiaolu Duan; Li Fu; Di Gu; Tuxiong Huang

WNT2-SOX4 positive feedback loop promotes chemoresistance and tumorigenesis by inducing stem-cell like properties in gastric cancer

ONCOGENE

IF7.3

2023-08-26

PREAI

Tan, Xiang-Yu; Li, Yu-Ting; Li, Hua-Hui; Ma, Li-Xiang; Zeng, Chui-Mian; Zhang, Tian-Tian; Huang, Tu-Xiong; Zhao, Xiao-Di; Fu, Li

NOTCH4ΔL12_16 sensitizes lung adenocarcinomas to EGFR-TKIs through transcriptional down-regulation of HES1

NATURE COMMUNICATIONS

IF15.7

2023-06-02

OAAI

Zhang, Bin; Dong, Shaowei; Wang, Jian; Huang, Tuxiong; Zhao, Pan; Xu, Jing; Liu, Dongcheng; Fu, Li; Wang, Lingwei; Wang, Guangsuo; Zou, Chang

Microfluidics-Enabled Nanovesicle Delivers CD47/PD-L1 Antibodies to Enhance Antitumor Immunity and Reduce Immunotoxicity in Lung Adenocarcinoma

ADVANCED SCIENCE

IF14.1

2023-05-03

OAAI

Su, Zhenwei; Dong, Shaowei; Chen, Yao; Huang, Tuxiong; Qin, Bo; Yang, Qinhe; Jiang, Xingyu; Zou, Chang

Roles and therapeutic implications of m6A modification in cancer immunotherapy

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-03-07

OAAI

Pan, Juan; Huang, Tuxiong; Deng, Zhenjun; Zou, Chang

Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma 靶向TROY介导的P85a/AKT/TBX3信号减弱肝癌的肿瘤干细胞并提高治疗反应

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2022-05-25

OAAI

Liu, Beilei; Fang, Xiaona; Kwong, Dora Lai-Wan; Zhang, Yu; Verhoeft, Krista; Gong, Lanqi; Zhang, Baifeng; Chen, Jie; Yu, Qianqian; Luo, Jie; Tang, Ying; Huang, Tuxiong; Ling, Fei; Fu, Li; Yan, Qian; Guan, Xin-Yuan

MAPK10 Expression as a Prognostic Marker of the Immunosuppressive Tumor Microenvironment in Human Hepatocellular Carcinoma

FRONTIERS IN ONCOLOGY

IF3.3

2021-08-02

OAAI

Li, Huahui; Li, Yuting; Zhang, Ying; Tan, Binbin; Huang, Tuxiong; Xiong, Jixian; Tan, Xiangyu; Ermolaeva, Maria A. A.; Fu, Li

WNT2-Mediated FZD2 Stabilization Regulates Esophageal Cancer Metastasis via STAT3 Signaling

FRONTIERS IN ONCOLOGY

IF3.3

2020-07-16

OAAI

Fu, Yufei; Zheng, Qi; Mao, Yingying; Jiang, Xiyi; Chen, Xin; Liu, Pei; Lv, Bin; Huang, Tuxiong; Yang, Jiao; Cheng, Yongran; Dai, Xiaoyi; Dai, Chunyan; Wang, Xi; Yin, Yifei; Song, Tengjiao; Jin, Weiyang; Zou, Chang; Chen, Tianhui; Fu, Li; Chen, Zhe

A new mouse esophageal cancer cell line (mEC25)-derived pre-clinical syngeneic tumor model for immunotherapy 一种新的小鼠食管癌细胞系 (mEC25) 衍生的临床前同系肿瘤模型，用于免疫治疗

CANCER COMMUNICATIONS

IF24.9

2020-06-08

OAAI

Huang, Tuxiong; Yang, Jiao; Liu, Beilei; Fu, Li

The immune landscape of esophageal cancer 食管癌的免疫景观

CANCER COMMUNICATIONS

IF24.9

2019-11-26

153

OAAI

Huang, Tu-Xiong; Fu, Li

Glucosyltransferase activity of Clostridium difficile Toxin B is essential for disease pathogenesis

GUT MICROBES

IF11

2015-06-19

OAAI

Yang, Zhiyong; Zhang, Yongrong; Huang, Tuxiong; Feng, Hanping

Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B

CELL RESEARCH

IF25.9

2014-12-30

171

OAAI

Yuan, Pengfei; Zhang, Hongmin; Cai, Changzu; Zhu, Shiyou; Zhou, Yuexin; Yang, Xiaozhou; He, Ruina; Li, Chan; Guo, Shengjie; Li, Shan; Huang, Tuxiong; Perez-Cordon, Gregorio; Feng, Hanping; Wei, Wensheng

Biochemical characterization of human peroxiredoxin 2, an antioxidative protein

ACTA BIOCHIMICA ET BIOPHYSICA SINICA

IF3.4

2012-09-01

PREAI

Yan, Sheng; Chen, Shaopei; Li, Zhendong; Wang, Haiying; Huang, Tuxiong; Wang, Xiaoning; Wang, Jufang

研究方向